Health
Study may offer an unexpected pathway for targeted treatment of brain tumors – News-Medical.Net
In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing…
In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody….
Continue Reading
-
Business18 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General16 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Business23 hours agoThis artificial intelligence (AI) stock will be the Nvidia of quantum computing by 2035
-
Noosa News18 hours agoLung cancer researchers identify ‘breakthrough’ patterns predictive of treatment success